Stay updated with breaking news from Nasdaq Xbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xenetic Biosciences Inc (NASDAQ:XBIO – Get Free Report)’s share price traded up 0.3% during mid-day trading on Wednesday . The company traded as high as $3.85 and last traded at $3.66. 19,068 shares changed hands during trading, an increase of 200% from the average session volume of 6,361 shares. The stock had previously closed at […]
Xenetic Biosciences Inc (NASDAQ:XBIO – Get Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 4,300 shares, a decline of 39.4% from the July 31st total of 7,100 shares. Approximately 0.3% of the company’s shares are short sold. […]
Xenetic Biosciences Inc (NASDAQ:XBIO – Get Free Report) saw a significant increase in short interest in July. As of July 15th, there was short interest totalling 32,700 shares, an increase of 52.8% from the June 30th total of 21,400 shares. Currently, 2.5% of the company’s stock are short sold. Based on an average daily trading […]
HC Wainwright lowered shares of Xenetic Biosciences (NASDAQ:XBIO – Get Rating) from a buy rating to a neutral rating in a report released on Tuesday, The Fly reports. HC Wainwright also issued estimates for Xenetic Biosciences’ Q2 2023 earnings at ($1.13) EPS, Q3 2023 earnings at ($1.12) EPS, Q4 2023 earnings at ($1.73) EPS, FY2023 […]
Xenetic Biosciences (NASDAQ:XBIO – Get Rating) and Leap Therapeutics (NASDAQ:LPTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership. Profitability This table compares Xenetic Biosciences and Leap Therapeutics’ […]